logo

For the Inventor, By the Inventor

Karachi, Pakistan

Muhammad Iqbal Choudhary

This inventor holds 22 USPTO granted patents and 15 published patent applications, primarily in Pharmaceutical Research. Top assignees: King Saud University, Other. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muhammad Iqbal Choudhary. Retrieved from https://idiyas.com/inventor/muhammad-iqbal-choudhary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 54.5

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Riyadh, SA (2017)
  • Karachi, PK (2011 - 2024)

Company Filing History:

goldMedal2 out of 788 
 
King Saud University
 patents
silverMedal18 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
Areas of Expertise:
Aromatase Inhibitors
Anti-Alzheimer's
Epilepsy Treatment
Neurogenesis
Cancer Therapeutics
Obesity Treatment
Diabetes Agents
Urease Inhibitors
Anti-inflammatory Compounds
Metabolic Disorders
Advanced Glycation End-products
22 patents (USPTO):Explore Patents
1. 12310980 - Synthesis of a potent aromatase inhibitor 17α-acetoxy-10β,11β-dihydroxy-progesterone for the treatment of ER+ breast cancer (2025-05-27),
2. 11939352 - Potent aromatase inhibitors through fungal transformation of anti-cancer drug testolactone: an approach towards treatment of breast cancer (2024-03-26),
3. 11643395 - Derivatives of 4-aminoantipyrine as anti-Alzheimers butyrylcholinesterase inhibitors (2023-05-09),
4. 11419833 - Nasally administered pharmaceutical composition for the treatment of epilepsy and related disorders (2022-08-23),
5. 11065211 - Isoxylitones mediated neurogenesis (2021-07-20),
6. 10849953 - Food supplement to alleviate symptoms of Parkinson's disease (2020-12-01),
7. 10765716 - Obesity treatment (2020-09-08),
8. 10550155 - Anticancer peptides (2020-02-04),
9. 10426806 - Anti-obesity effect oflinn. extracts to prevent and treat metabolic disorders (2019-10-01),
10. 10183000 - 2, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes (2019-01-22),
11. 9802894 - α-glucosidase inhibitors (2017-10-31),
12. 9688628 - Drug repositioning: urease inhibitory activity of (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (captopril) (2017-06-27),
13. 9527820 - Diethylammonium salts of phenyl-substituted thiobarbituric acid as anti-diabetic agents (2016-12-27),
14. 9447057 - Schiff bases of thiazoles: a new class of ureases inhibitors (2016-09-20),
15. 9387198 - Inhibitors of advanced glycation end-products (ages)formation (2016-07-12),

Title:

Breaking Boundaries in Pharmaceutical Innovations: The Brilliant Mind of Muhammad Iqbal Choudhary

Introduction:

Muhammad Iqbal Choudhary, a distinguished inventor hailing from Karachi, Pakistan, has set new standards in pharmaceutical research and development. With an impressive portfolio of 21 patents, his groundbreaking work has significantly advanced the field of medicinal chemistry and drug discovery.

Latest Patents:

Choudhary's most recent patents showcase his exceptional prowess in developing novel treatments for complex diseases. One patent focuses on the potent aromatase inhibitors derived through fungal transformation of the anti-cancer drug testolactone. These inhibitors have shown promising results in combating estrogen-positive breast cancers, marking a significant step forward in cancer therapy. Another patent highlights the use of derivatives of 4-aminoantipyrine as anti-Alzheimer's butyrylcholinesterase inhibitors, offering new hope in the treatment of Alzheimer's Disease and related conditions.

Career Highlights:

Throughout his career, Choudhary has made remarkable contributions to the pharmaceutical industry. He has been associated with prestigious institutions such as King Saud University, where he has led groundbreaking research projects. Choudhary's dedication to innovation and scientific excellence has earned him widespread recognition in the field of medicinal chemistry.

Collaborations:

Choudhary's collaborative efforts with esteemed colleagues Atta-Ur Rahman and Atia-Tul Wahab have further enriched his research endeavors. Their synergy has led to the development of revolutionary pharmaceutical solutions, cementing Choudhary's reputation as a visionary inventor.

Conclusion:

In conclusion, Muhammad Iqbal Choudhary's exceptional talent and unwavering commitment to scientific innovation have reshaped the landscape of pharmaceutical research. His groundbreaking patents and collaborative efforts stand as a testament to his enduring legacy in the field of medicinal chemistry. Choudhary's relentless pursuit of excellence continues to inspire future generations of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…